Agios Pharmaceuticals reported $53.6M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amgen AMGN:US USD 14.33B 1.71B
Arrowhead Research ARWR:US USD 138.85M 10.64M
Astellas Pharma 4503:JP JPY 761.41B 20.87B
AstraZeneca AZN:LN USD 24.85B 3.04B
Bayer BAYN:GR EUR 33.17B 471M
Biogen BIIB:US USD 3.93B 1.09B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Daiichi Sankyo 4568:JP JPY 428.1B 21.28B
Eli Lilly And LLY:US USD 15.65B 32.2M
Exelixis EXEL:US USD 301.73M 2.79M
Gilead Sciences GILD:US USD 10.42B 1.2B
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Immunogen IMGN:US USD 103.64M 16.57M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
JAZZ PHA JAZZ:US USD 812.95M 107.51M
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Moderna Inc MRNA:US USD 6.81B 5M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Novartis NVS:US USD 28.16B 514M
Novartis NOVN:VX USD 28.16B 514M
Puma Biotechnology PBYI:US USD 59.99M 3.15M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Seattle Genetics SGEN:US USD 726M 117.48M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
YTE INCY:US USD 1.01B 79.92M